Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexandra Petraina
Observed name:
Petraina, Alexandra
Institution:
Maastricht University
Observed institutions:
University of Kassel,
University of Geneva,
Merck & Co., Inc., Rahway, NJ, USA (United States),
Tohoku University,
Maastricht University,
London School of Hygiene & Tropical Medicine,
Cyclerion (United States),
Swiss National Science Foundation
show all 8
ORCID:
0000-0002-1667-0266
Observed ORCID:
0000-0002-1667-0266
OpenAlex ID:
A5027698781
On the Clinical Pharmacology of Reactive Oxygen Species
2020
·
Ana I. Casas
, Cristian Nogales
, et al.
·
Pharmacological Reviews
·
140
PDF
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology
2021
·
Alexandra Petraina
, Cristian Nogales
, et al.
·
Cardiovascular Research
·
59
PDF
Meeting abstracts from the 9th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
2019
·
Nogales, Cristian
, Anastasi, Elisa
, et al.
·
Journal of Translational Medicine
·
3
PDF
Revisiting soluble guanylate cyclase pharmacology: Additive potential of stimulators and activators
2025
·
Alexandra Petraina
, Mahmoud H. Elbatreek
, et al.
·
Biomedicine & Pharmacotherapy
·
2
NOS recoupling with L-citrulline, folate, and vericiguat in a NOX5-positive subgroup of HFpEF patients: A Phase IIa proof-of-concept trial
2024
·
Rafael De la Espriella
, Cristian Nogales
, et al.
PDF
Extending apo-sGC to haem-sensing proteins and a landscape of haem mimetic pharmacophores with broad applications
2024
·
Mahmoud H. Elbatreek
, Ruma Banerjee
, et al.
PDF
A representative dementia outpatient sample from the south of Brazil for mechanism-based biomarker identification: epidemiological profile
2024
·
Liana Lisboa Fernandez
, André Luiz Rodrigues Palmeira
, et al.
·
Reunião de Pesquisadores em Doença de Alzheimer e Desordens Relacionadas (RPDA)
PDF
Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications
2023
·
Alexandra Petraina
, Mahmoud H. Elbatreek
, et al.
PDF
Why the way we define diseases prevents innovation and precision medicine
2023
·
Zeinab M. Mamdouh
, Elisa Anastasi
, et al.
PDF
On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications
2023
·
Alexandra Petraina
, Mahmoud H. Elbatreek
, et al.
PDF
Mechanism-based diagnosis of cyclic GMPopathies and pharmacological interventions
2023
·
Alexandra Petraina
·
Research Publications (Maastricht University)
PDF
Mechanistic endotyping of the ROS/cGMP disease cluster in the Estonian Biobank
2023
·
Cristian Nogales Calvo
, Jaanika Kronberg
, et al.
PDF
D5.3 - Initial whitepaper on rational for a wet-lab technology platform for patient recruitment
2023
·
Thomas Krahn
, Sara Campos
, et al.
PDF
An organ-agnostic drug repurposing strategy for dementia: Pre-clinical validation of network pharmacology to treat cerebrovascular dysfunction and cognitive impairment
2022
·
Mayra Pacheco Pachado
, Alexandra Petraina
, et al.
PDF
Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module
2022
·
Alexandra Petraina
, Mahmoud H Elbatreek
, et al.
PDF
Network modules as molecular disease definitions for mechanism-based endotyping anddrug repurposing
2022
·
Cristian Nogales Calvo
, Ana I. Casas
, et al.
PDF
Show more works
View as search
Works count:
17
Citation count:
204
H-index:
3
I10-index:
2
Year
Topic
Type